uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted April 10, 2021

Companies Deceived Consumers About Fish Oil for Liver Disease, Says FTC

On April 1, 2021, the Federal Trade Commission (FTC) announced that fish oil supplement manufacturer BASF SE and its U.S. distributor, DIEM Labs, will pay a total of over $416,000 to settle FTC charges that the companies deceptively marketed two dietary fish oil supplements with claims that they treated liver disease.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at